Skip to main content
Clinical Trials/CTRI/2018/05/013634
CTRI/2018/05/013634
Other
Phase 1

A randomized controlled clinical trial to compare the efficacy of standard dose of steroids vs reduced dose in treating relapses in children with steroid sensitive nephrotic syndrome - Stdvsred

Suprita Kalra0 sites27 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: null- Children with Steroid sensitive Nephrotic Syndrome with infrequent relapses
Sponsor
Suprita Kalra
Enrollment
27
Status
Other
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 12, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Suprita Kalra

Eligibility Criteria

Inclusion Criteria

  • all children with idiopathic nephrotic syndrome on stable immunosuppression(either long term alternate day steroids,levamisole or mycophenolate mofetil) or on no immunosuppresion for last 6 months with infrequent relapses defined as less than 2 relapses in last 6 months

Exclusion Criteria

  • children started on a steroid sparing agent in last 6 months due to frequent relapses or steroid dependence,
  • Children with steroid resistant nephrotic syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials